⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18196765 | 1.00 | — | — | |
| SCHEMBL8090379 | 0.75 | — | — | |
| SCHEMBL693062 | 0.75 | — | — | |
| SCHEMBL20163782 | 0.73 | — | — | |
| SCHEMBL18715489 | 0.72 | — | — | |
| SCHEMBL18715746 | 0.71 | — | — | |
| SCHEMBL23446397 | 0.71 | — | — | |
| SCHEMBL24441249 | 0.71 | — | — | |
| SCHEMBL20833282 | 0.71 | — | — | |
| SCHEMBL23073834 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 120 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260070872-A1 | COMPOUNDS AND METHODS FOR TREATING INFLAMMATORY DISORDERS | UNIV LOUISIANA STATE (US) | 2026-03-12 | — | — | US | disclosed |
| US-12551469-B2 | Sphingosine kinase 2 inhibitor for treating coronavirus infection | REDHILL BIOPHARMA LTD. (IL) | 2026-02-17 | — | — | US | disclosed |
| EP-4685135-A2 | COMPOUNDS AND USES THEREOF FOR TREATING INFLAMMATION AND MODULATING IMMUNE RESPONSES | Board of Supervisors of Louisiana State University and Agricultural and Mechanical College (US) | 2026-01-28 | — | — | EP | disclosed |
| EP-3952851-B1 | COMPOUNDS AND USES THEREOF FOR TREATING INFLAMMATORY DISORDERS | UNIV LOUISIANA STATE (US) | 2025-12-03 | — | — | EP | disclosed |
| US-20250353808-A1 | 5-METHOXYMETHYL AND 5-HYDROXYMETHYL PHENETHYLAMINES | 2A BIOSCIENCES, INC. | 2025-11-20 | — | — | US | disclosed |
| US-12410153-B2 | Compounds, compositions and methods | AVALO THERAPEUTICS, INC. (US) | 2025-09-09 | — | — | US | disclosed |
| US-20250277200-A1 | ENGINEERED CPN1 CONSTRUCTS AND VARIANTS | VERTEX PHARMACEUTICALS INCORPORATED | 2025-09-04 | — | — | US | disclosed |
| EP-4452981-B1 | TRIAZOLONE DERIVATIVE SALT AS NEUTROPHIL ELASTASE INHIBITOR | CHIESI FARM SPA (IT) | 2025-08-27 | — | — | EP | disclosed |
| US-12398093-B2 | Compounds and methods for treating inflammatory disorders | BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) | 2025-08-26 | — | — | US | disclosed |
| EP-3527632-B1 | INK COMPOSITION, ORGANIC LIGHT-EMITTING ELEMENT USING SAME, AND FABRICATION METHOD THEREOF | LG CHEMICAL LTD (KR) | 2025-07-02 | — | — | EP | disclosed |
| US-20130041027-A1 | Organo-Arsenoxide Compounds and Use Thereof | NEWSOUTH INNOVATIONS PTY LIMITED (AU) | 2013-02-14 | — | — | US | disclosed |
| US-8268883-B2 | Organo-arsenoxide compounds and use thereof | NEWSOUTH INNOVATIONS PTY LIMITED (AU) | 2012-09-18 | — | — | US | disclosed |
| US-20100041749-A1 | Organo-Arsenoxide Compounds and Use Thereof | NEWSOUTH INNOVATIONS PTY LIMITED (AU) | 2010-02-18 | — | — | US | disclosed |
| US-20100016550-A1 | Methods for Site-Specific Pegylation | IPSEN PHARMA S.A.S. (FR) | 2010-01-21 | — | — | US | disclosed |
| EP-2069371-A1 | ORGANO-ARSENOXIDE COMPOUNDS AND USE THEREOF | Newsouth Innovations Pty Limited (AU) | 2009-06-17 | — | — | EP | disclosed |
| WO-2008052279-A1 | ORGANO-ARSENOXIDE COMPOUNDS AND USE THEREOF | NEWSOUTH INNOVATIONS PTY LIMITED (AU) | 2008-05-08 | — | — | WO | disclosed |
| EP-1100801-A2 | USE OF CYSTEINE DERIVATIVES FOR PREPARING A MEDICINE FOR TREATING PATHOLOGIES RESULTING FROM THE FORMATION OF HETEROTRIMERIC G PROTEIN | SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) | 2001-05-23 | — | — | EP | disclosed |
| EP-1087981-A2 | PRENYL TRANSFERASE INHIBITORS | SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES S.A.S. (FR) | 2001-04-04 | — | — | EP | disclosed |
| WO-2000002881-A2 | USE OF CYSTEINE DERIVATIVES FOR PREPARING A MEDICINE FOR TREATING PATHOLOGIES RESULTING FROM THE FORMATION OF HETEROTRIMERIC G PROTEIN | SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (SCRAS) (FR) | 2000-01-20 | — | — | WO | disclosed |
| WO-1999065922-A2 | PRENYL TRANSFERASE INHIBITORS | SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES S.A.S. (FR) | 1999-12-23 | — | — | WO | disclosed |